Market · Tracked since 2024

    Pharma Commercial Analytics Platforms

    25 vendors tracked across 2 PeMa editions since 2024. Axtria, Veeva Systems and ZS have been Leaders in 2 of them.

    25

    Vendors tracked

    2

    PeMa editions

    2

    Current reports

    4

    Leaders today

    PeMa Live · Pharma Commercial Analytics Platforms

    How each vendor’s band has changed, edition by edition

    Every edition places vendors relative to the others evaluated that year, so we compare bands across years rather than dot positions.

    2025 edition · snapshot

    18 vendors placed · positions relative to this edition only

    LeadersSeasonedChallengersGrowth

    Positions are relative to the vendors evaluated in each edition. A dot moving does not by itself mean a vendor improved or declined.

    Vendor20242025Leader
    AxtriaLL2×
    Veeva SystemsLL2×
    ZSLL2×
    DomoL–1×
    IQVIA–L1×
    JMPL–1×
    MedidataL–1×
    DataZymesCC0×
    IntegriChainSG0×
    P360CC0×
    TelliusCS0×
    WhizAICS0×
    LeaderSeasonedChallengerGrowth– not evaluated that edition

    No open study right now. Get notified when the next Pharma Commercial Analytics Platforms edition opens.

    No vendors or reports associated with this market yet.

    FAQ

    Questions about this market

    In the 2025 Pharma Commercial Analytics Platforms PeMa Quadrant, 4 vendors were placed as Leaders: Axtria, IQVIA, Veeva Systems and ZS.

    AIM Research tracks 0 vendors in Pharma Commercial Analytics Platforms, across 2 PeMa editions.

    Since 2024, the study has run 2 editions. It placed 16 vendors in 2024 (6 Leaders) and 18 in 2025 (4 Leaders).

    No Pharma Commercial Analytics Platforms study is scheduled right now. Sign up on this page to be notified when the next edition opens.